ASCO 2018: The latest in bladder cancer treatments from parp Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 10 min 15 sec ✓ Published: 03-Jun-2018
Description: Prof Thomas Powles (Barts Cancer institute, London) and Prof Shahrokh F. Shariat (Vienna General Hospital, Germany) discuss the current patient eligibility changes within immuno-oncology following new guidance from EMA/FDA and share their thoughts on emerging neoadjuvant data with checkpoint inhibitors following some investigator initiated trials.nnBoth experts share their views on recently presented data on IDO1 inhibitors and pan-FGFR kinase inhibitors and signpost that future management of ur
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)